Robert H. Rosen
2013
In 2013, Robert H. Rosen earned a total compensation of $8.6M as President and Chief Commercial Officer at Heron Therapeutics, a 49% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $317,188 |
|---|---|
| Option Awards | $7,872,000 |
| Salary | $453,785 |
| Total | $8,642,973 |
Rosen received $7.9M in option awards, accounting for 91% of the total pay in 2013.
Rosen also received $317.2K in non-equity incentive plan and $453.8K in salary.
Rankings
In 2013, Robert H. Rosen's compensation ranked 550th out of 12,286 executives tracked by ExecPay. In other words, Rosen earned more than 95.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 550 out of 12,286 | 96th |
Division Manufacturing | 169 out of 4,614 | 96th |
Major group Chemicals And Allied Products | 40 out of 1,466 | 97th |
Industry group Drugs | 24 out of 1,160 | 98th |
Industry Pharmaceutical Preparations | 22 out of 890 | 98th |
Source: SEC filing on April 29, 2016.
Rosen's colleagues
We found three more compensation records of executives who worked with Robert H. Rosen at Heron Therapeutics in 2013.